4.7 Editorial Material

Brain-specific biomarkers: on the winding path to accessibility and clinical relevance

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Brain--specific biomarkers in urine as a non--invasive approach to monitor neuronal and glial damage

Konstantin Kohlhase et al.

Summary: This study evaluates the measurement of GFAP, NfL, UCH-L1, and τ-tau in urine of patients with acute cerebral damage. NfL showed the most accurate correlation between urine and serum concentrations in patients with intact kidney function.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Serum GFAP and NfL Levels Differentiate Subsequent Progression and Disease Activity in Patients With Progressive Multiple Sclerosis

Christian Barro et al.

Summary: Neurodegeneration and astrocytic activation are characteristic pathological features of progressive MS. sNfL and sGFAP can be used as tools to stratify patients based on progression and disease activity status.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

Review Clinical Neurology

Blood GFAP as an emerging biomarker in brain and spinal cord disorders

Ahmed Abdelhak et al.

Summary: Blood-derived biomarkers, such as glial fibrillary acidic protein (GFAP), hold promise in the diagnosis and prognosis of neurological diseases. However, there are limitations that hinder the widespread clinical use of GFAP as a biomarker.

NATURE REVIEWS NEUROLOGY (2022)

Article Clinical Neurology

Brain-specific biomarkers in urine as a non-invasive approach to monitor neuronal and glial damage

Konstantin Kohlhase et al.

Summary: This study evaluates the quantitative measurability of GFAP, NfL, UCH-L1, and t-tau in the urine of patients with acute cerebral damage. The results show that NfL has the strongest effect size in urine and is significantly correlated with serum concentrations, especially in patients with intact kidney function.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Review Clinical Neurology

Neurofilaments as biomarkers in neurological disorders

Michael Khalil et al.

NATURE REVIEWS NEUROLOGY (2018)